Sugar- or artificially-sweetened beverage consumption, physical activity, and risk of cardiovascular disease in adults: a prospective cohort study
Pacheco LS, Tobias DK, Li Y, et al.
Am J Clin Nutr. 2024:S0002-9165(24)00001-7.
Leggi
Breaking news
Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study
Krishnan A, Schneider CV, Hadi Y, et al.
Diabetologia. Pub. online 20 Dec 2023.
Leggi
Diagnostic yield of a proactive strategy for early detection of cardiovascular disease versus usual care in adults with type 2 diabetes or chronic obstructive pulmonary disease in primary care in the Netherlands (RED-CVD): a multicentre, pragmatic, cluster-randomised, controlled trial
Groenewegen A, Zwartkruis VW, Rienstra M, et al.
Lancet Public Health. 2023:S2468-2667(23)00269-4.
Leggi
Do glycaemic treatment targets affect the perinatal mental health status of women with gestational diabetes? – Data from the TARGET Trial
Ohene-Agyei P, Tran T, Harding JE, Crowther CA
BMC Pregnancy Childbirth. 2023;23(1):869.
Leggi
The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during Ramadan
Al-Sofiani ME, Petrovski G , Al Shaikh A, et al.
Diabetes Obes Metab. Pub. online 27 Dec 2023.
Leggi
Daily low-dose aspirin and incident type 2 diabetes in community-dwelling healthy older adults: a post-hoc analysis of efficacy and safety in the ASPREE randomised placebo-controlled trial
Zoungas S, Zhou Z, Owen AJ, et al.
Lancet Diabetes Endocrinol. 2023:S2213-8587(23)00327-3.
Leggi
Once‐weekly semaglutide reduces the risk of cardiovascular events in people with type 2 diabetes and polyvascular disease: A post hoc analysis
Kobo O, Cavender MA, Jensen TJ, et al.
Diabetes Obes Metab. Pub. online 11 Dec 2023.
Leggi
Current status and principles for the treatment and prevention of diabetic foot ulcers in the cardiovascular patient population: a scientific statement from the american heart association
Gallagher KA, Mills JL, Armstrong DG, et al.
Circulation. Pub. online 14 Dec 2023.
Leggi
Advancing type 2 diabetes therapy with iGlarLixi in older people: Pooled analysis of four randomized controlled trials
Munshi M, Ritzel R, Jude EB, et al.
Diabetes Obes Metab. Pub. online 11 Dec 2023.
Leggi
Translating trial results into interpretable risk estimates: systematic analysis of cardiorenal outcome trials of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors
Rizzi A, Kloecker DE, Pitocco D, et al.
NMCD. Pub. online 19 Dec 2023.
Leggi